Katie King, co-founder and chief executive of BioOrbit, discusses how her company is building pharmaceutical manufacturing facilities designed to operate in space and why that could fundamentally transform how the production of medicine works.
BioOrbit is a British space tech company that aims to use the irreplicable conditions of outer space to improve the development of drugs that could massively shape how humans treat some of Earth’s most dangerous conditions.
Listen to the full episode here, along with all previous episodes of the UKTN Podcast.
The UKTN Podcast is sponsored by HSBC Innovation Banking, which offers flexible banking solutions for startups, scaleups, growth businesses, investors and those working towards IPO.
Throughout the series, the UKTN Podcast speaks to some of the key movers and shakers from UK tech. We’ll learn growth strategies from both seasoned and up-and-coming founders, hear market sentiments from investors, and question policymakers on the decisions impacting the country’s innovation economy.
Sign up for our podcast newsletter to ensure you don’t miss an episode.
